Exonate plans to initiate phase 2b CLEAR-DE trial for EXN407 topical formulation for NPDR
The first-in-class, twice-daily topical formulation is intended for the treatment of non-proliferative diabetic retinopathy and diabetic macular edema.
National Vision awards scholarships to optometric students during NOA Convention 2025
A total of $7000 in scholarships was awarded to 3 optometry students as part of the National Optometric Student Association (NOSA) scholarship program.
Phase 3 study assessing LUMIFY Preservative Free and LUMIFY eye drops meets primary end point
The primary objective of the study was to demonstrate that LUMIFY Preservative Free redness reliever eye drops is non-inferior to LUMIFY redness reliever eye drops in reducing ocular redness.
Ziemer USA, CorneaGen launch GALILEI CTAK module for GALILEI diagnostic platform
The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.
Case report: Gyrate atrophy of the choroid and retina
Gyrate atrophy of the choroid and retina is a form of choroidal sclerosis and is a rare, progressive, autosomal recessive, inherited genetic disease that primarily affects the ocular tissue.
CooperVision recognized during 2025 Puerto Rico Manufacturers Association Awards
The company was presented with the PRMA President’s Award, Platinum Recycling Award, and recognitions in Leadership in Environmental Performance.
How much is enough? Seeking remission from type 2 diabetes
What we should be telling our patients about the remission of type 2 diabetes with weight loss.
Takeaways from this week in optometry: July 21 - July 25
Catch up on the top stories in optometry during the week of July 21-July 25.
HOYA introduces new HOYA Polarized Lenses with Lumacore Mirrors lens
The enhanced clarity in the lens helps reduce glare and enhance visual comfort, according to the company.
Eye care organizations, researchers launch campaign advocating for vision research
The campaign provides tools to patients, researchers, clinicians, industry, and advocates with tools to tell their stories that advocate for vision research.
VA-developed RainDrop Dispenser Aid aims to simplify use of single-use eye drops for patients with arthritis, tremors
The tool is designed to help with the application of mono-dose, dry eye eye drop vials more easily and accurately.
Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary end point
The solution missed the primary end point of the trial, which was complete resolution of debris after 6 weeks of twice-daily dosing.
EyeSouth Partners adds St Lucie Eye of Florida to partner network
The EyeSouth affiliate network now includes more than 320 doctors providing medical and surgical eye care services at over 235 locations.
Santen begins European rollout of low-dose atropine for myopia in Germany
Santen introduces low-dose atropine in Germany, marking a significant advancement in myopia management for children amid a global epidemic.
Orbis Flying Eye Hospital touches down in Rwanda to provide training, education to ECPs
This will be the Flying Eye Hospital’s first visit to Rwanda.
Survey finds majority of US patients delaying eye care despite experiencing poor eyesight, eye health
Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.
Healing damaged collagen in the eye with topical polypeptides in patients with myopia
New research reveals collagen mimetic peptides may effectively restore ocular tissue stiffness, offering hope for myopia and other eye diseases.
Eye care professionals report moderate-to-high satisfaction with lifitegrast treatment for dry eye
Ophthalmologists report high satisfaction with lifitegrast for dry eye treatment, noting rapid symptom relief and effective management in diverse patient populations.
Minnesota passes first scope expansion bill in over 2 decades
The bill will make 3 changes that enhance oral medication usage, with 1 change expanding access to in-office procedures.
Takeaways from this week in optometry: July 14 - July 18
Catch up on the top stories in optometry during the week of July 14-July 18.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "RainDrop Dispenser Aid Image credit: Rain Eye Drops")
%2520for%2520blepharitis%2520fails%2520to%2520meet%2520primary%2520end%2520point%2520-%2520%25C2%25A9patpitchaya%25E2%2580%2594stock.adobe.com.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary end point - Image credit: ©patpitchaya—stock.adobe.com")
